August 2009
Matrix becomes a privately held Mylan subsidiary
June 2009
Mylan announces successful Matrix delisting offer
January 2007
Mylan Laboratories acquires a 71.5% controlling interest in Matrix Laboratories Limited
January 2007
Matrix receives “Fastest Wealth Creator" award in Motilal Oswal Wealth Creation Study for 2006
May 2006
Matrix receives “Best Management” award from the government of Andhra Pradesh
December 2005
Matrix receives "Fastest Wealth Creator" award in Motilal Oswal Wealth Creation Study for 2005
December 2005
Matrix announces decision to acquire controlling stake in Concord Biotech, an Ahmedabad-based biotechnology company with fermentation and bio-catalytic technology capabilities and U.S. Food and Drug Administration (FDA) approved API manufacturing facilities
November 2005
Matrix receives the National Award for R&D Efforts in Industry for 2005 in Pharmaceuticals/Chemical Sector from the Department of Scientific & Industrial Research, Government of India, Ministry of Science and Technology
June 2005
Matrix Laboratories Limited acquires a controlling stake in Docpharma, based in Belgium
April 2005
Matrix and Aspen Pharmacare Holdings Limited form joint ventures in India and South Africa
February 2005
Matrix announces strategic alliance with MCHEM Pharma Group of China
January 2005
Matrix receives "Fastest Wealth Creator" award in Motilal Oswal Wealth Creation Study for 2004
January 2005
Matrix purchases finished dosage facility located near Nashik, about 150 km from Mumbai
April 2004
Matrix signs definitive agreements with India Newbridge Investments Limited and Maxwell (Mauritius) Pte. Limited
March 2004
Matrix’s Board of Directors approves the company’s merger with Vera Laboratories Limited, Fine Drugs and Chemicals Limited, Medikon Laboratories Limited and Calibre Engineering Private Limited
March 2004
Matrix receives U.S. FDA approval for its manufacturing facility at Jeedimetla, near Hyderabad
November 2003
Matrix sets up two 50:50 joint venture companies, one in India and the other in Ireland
October 2003
Matrix signs an agreement with the William J. Clinton Foundation to supply ARVs for the treatment of HIV/AIDS patients in sub-Saharan Africa, South Africa and the Caribbean countries
May 2003
Matrix merges with Vorin Laboratories Limited and Medicorp Technologies India Limited
April 2003
Matrix successfully files process patent applications for four products at the Indian Patent Office
| 
